BLRX - 1.12 Pre-market now at 1.17/1.18 BioLineRx Reports Positive Results From Trial of BL-8040 to Treat Acute Myeloid Leukemia; Shares Up 8% Early http://stockcharts.com/c-sc/sc?s=BLRX&p=D&b=5&g=0&i=t34972365995&r=1512392362946 http://stockcharts.com/c-sc/sc?s=BLRX&p=W&b=5&g=0&i=t58261562957&r=1512392343144